Maura In The News

Maura Hennigan's Position on Boston University's Biolab

In 2004, Boston University Medical Center (BUMC) applied to the federal government for money to build a lab where researchers will work on microbes used for bioterrorism and biowarfare.  BU officials have demonstrated through word and deed, that they are incapable of safely handling such dangerous microbes and unwilling to put public safety ahead of their financial interests. Mayor Menino has chosen to overlook these shortfalls and has been an unwavering supporter of BU and the project developers.

This proposal is driven by BUMC’s desire to have access to the government subsidies they expect to be flowing from the Dept. of Homeland Security. BUMC’s proposed lab would bring no benefit to the city.  It will bring great risk and no reward.  I am strongly opposed to this lab, as currently proposed by Boston University.

Background

Following the anthrax attacks of Oct. 2001, President Bush seized on public fear to push for expanding U.S. research in the area of bioweapons and bioterrorism agents.  This project, named Bioshield, channels money from the Dept. of Homeland Security through the National Institute of Allergies and Infectious Disease (NIAID) to laboratories set up to work with the microbes used as biological weapons.  The project is touted as defensive in nature, intended only to develop vaccines and other countermeasures to bioterrorism. However, the anthrax used in the attacks in 2001 was stolen from a similar “defensive” program within the Defense Dept., and it was used to kill and injure several individuals as well as cause billions of dollars in damage.  The National Academy of Sciences has warned against the uncontrolled expansion of experiments with these dangerous organisms.

Under Project Bioshield, BUMC applied for a grant to build a Biosafety Level 4 lab (BSL4). These labs are designed to work with the most contagious and deadly diseases that have no cures. BUMC intends to build this lab in the heart of Boston, in the South End/Roxbury area. Since word of this lab has been made public, citizens groups have been mobilizing to prevent this lab from being built in our city (http://www.ace-ej.org/BiolabWeb/biolab.html).

BU’s proposed lab will not be an attraction for the biotech industry.

Mayor Menino and other supporters of BUMC’s proposed lab claim that this lab will be a magnet for the biotech industry. It seems to have escaped Mayor Menino that the Boston area is booming with biotech already. There is not a biotech or pharmaceutical company that is not already here or is planning on opening an office in Boston .  Biotech is not interested in BSL4 labs.  The biotech industry is centered in Boston and San Francisco, areas that have great universities where information flows openly.  Biotech has not sprung up around the existing BSL4 labs at the CDC in Atlanta or at Ft. Dettrich, Maryland.  BSL4 and the military projects that go on there lead to secrecy, and that is not attractive to biotech.

Biotech is interested in developing blockbuster drugs for chronic conditions. They are not interested in vaccines and are barely interested in infectious disease prevention. This is evidenced by their unwillingness to even produce a flu vaccine, which is the domain of government labs.

BU’s proposed lab will not add to Boston’s job pool.

BU claims that the construction of the lab will generate 1,300 temporary construction jobs and 660 permanent jobs.  This would be true of any project at that site. BU has been totally disingenuous in their Draft Environmental Impact Statement, stating that if their BSL4 lab does not get built, that property will go fallow. This lot is highly desirable property that would easily be filled with any biomedical research facility. If the lot remains empty, it is because BU wishes to punish the community for opposing their project.

BU’s proposed lab will put our tourism industry at risk

We are putting one of our most lucrative industries at risk.  If there is even a rumor of a strange disease with this lab in town, Boston’s tourism industry will be dead for some period of time. A striking example was the effect of the SARS outbreak on tourism in Toronto.   Even our own Chinatown suffered a huge drop in visitors, even though there was no connection to the SARS outbreak.

BU’s recent tularemia outbreak revealed total breakdown in biosecurity.

In May and Sept. 2004, three researchers in a Boston University lab contracted tularemia while working with this biowarfare microbe. The outbreak of this biowarfare microbe was not discovered by B.U. until Oct. 2004.  It was not revealed to the public until Jan. 2005, after the city and state review process for their proposed lab was finalized.

This outbreak of tularemia from BU’s laboratories is worrisome not because it led to the infection of the general public.  It did not. However, it does give us insight into how B.U. operates labs working with bioterrorism agents.  The experiments done with tularemia are exactly the same experiments they plan on doing with much more deadly organisms in their proposed BSL4 lab.  The tularemia outbreak uncovered a complete breakdown in BU's biosecurity:

1) The researchers did not follow the mandatory protocol nor did they use the available safety equipment.

2) The bacteria used in the experiments got mixed up and an infectious form was used when they thought they were using a non-infectious strain.

3) Researchers became ill with the disease that they were working on, one to the point of hospitalization. None of these highly trained professionals noticed this outbreak.

4) Researchers in the lab tested their own blood in August 2004 and found that they were positive for exposure to tularemia. What should have been a very disturbing finding did not trigger any alarms at BUMC.

5) These experiments were not reviewed by the Institutional Biosafety Committee prior to the start of the experiment.  This was a flagrant violation of university and federal policy.  It also eliminated the only avenue of public oversight into the lab activity.

6) BU did not follow public safety protocols of promptly informing the public health officials of the outbreak of this bioterrorism agent. They are required to report the outbreak within 24 hours of suspecting the outbreak. They waited almost two weeks.

7) B.U. officials and Mayor Menino intentionally kept this important information from the public during the lab application review process, choosing to protect the financial interests of the university and developers over public safety concerns.

BU had a complete breakdown of biosafety with this relatively mild, curable bacteria and now they say they are ready to work with deadly, incurable organisms. The tularemia outbreak has proven that they are not.

BU has provided a highly flawed Environmental Impact and worst-case scenario assessment for their lab proposal.

The assessment of a worst-case release is extremely superficial at best. BU has chosen anthrax as their released organism. In assessing the plume of contamination that would be released from the lab, they measure the exposure of individuals at a single point at ground level.  A true assessment of the exposure must include a 3-D model of dispersal in the area, taking into account buildings and the presence of people at many elevations throughout the plume. Localized wind patterns may lead to concentrations of anthrax spores in discreet spots within the neighborhood.

The danger posed to community depends not only on the nature of the released organism, but also on the health and available healthcare of the resident population. It is known that the population around the proposed site suffers abnormally high incidences of asthma and other respiratory diseases.  The population is also under-insured and may not have access to medical care. These factors must be taken into account to get a realistic picture of the risk posed by this lab to the neighborhood.

The choice of anthrax as the studied organism does not take into account the much greater danger posed by a true contagion.  Accidental or intentional release of an organism that is spread from person to person poses a very different set of very serious health risks. This must also be included in a true assessment of a worst-case release.

BU’s Environmental Impact Statement does not look at the dangers posed by transport of infectious agents through the neighborhood going to and from the lab.

Jeanne Guillemin has conducted an extensive survey at the site of the world’s worst release of weaponized anthrax in Sverdlovsk, Russia.  Her comments on BU’s assessment can be found at www.ace-ej.org/BiolabWeb/Biolabdocs/ Guillemincommentsandcoverpage.pdf

BU has a long history of illegal dumping of toxic materials into the environment.

BU’s failure to report the outbreak of tularemia from its lab is only the latest in a long list of violations of existing environmental laws.  The summary can be found at http://www.ace-ej.org/BiolabWeb/healthandsafety.html.

BU’s proposed lab would be operated in violation of long-standing city restrictions.

The city has had restrictions in place for over 20 years that restrict using recombinant DNA technology in a BSL4 lab.  Boston Public Health Commission’s Recombinant DNA (rDNA) Technology Use Regulations, Section 3.01 explicitly states: “rDNA use requiring containment defined by the Guidelines as ‘BSL4’ shall not be permitted in the City of Boston.”  In July 2004, BUMC Associate Provost of Research, Dr. Mark Klempner, sent a letter to the Commission attempting to explain how such restrictions will not apply to BU’s proposed lab, since they are performing “legitimate” research.  With this letter, BU officials demonstrated their blatant disregard of existing city authority over their lab.

Biosecurity can be better protected with Universal Healthcare.

Along with the moral and financial benefits, universal healthcare will greatly increase our defense against bioterrorism.  Under Project Bioshield, President Bush proposes to blanket the country with as-yet-undeveloped biosensors that will alert us to the presence of a biological attack. Instead, he should take advantage of the hundreds of millions of “biosensors” already in place in the country: the citizens.  If every citizen were able to visit a doctor on a regular basis, we would quickly detect that a new disease has emerged.  This was the finding in Feb. 2003 of JASON, an independent scientific advisory group that provides consulting services to the U.S. government on matters of defense science and technology. Universal healthcare is how we would truly develop biosecurity.

Spreading this dangerous dual-use technology will make us more vulnerable to biological attack.

The National Academy of Sciences published a report stating that the expansion of the BSL4 system in the U.S. will lead to the spreading of technology that can be used for good as well as very evil purposes.  Scientists throughout the country have written that any expansion of this area of research should take place in a completely open and transparent manner and in the context of international cooperation. Proceeding in secrecy will lead to greater suspicion and an increase in a biological arms race.  That will decrease our own biosecurity.

In addition, please see the following online material that reinforces the arguments presented here:

Buying Biosafety — Is the Price Right?
(The New England Journal of Medicine © 05/20/2004)

There are real questions to be asked about the wisdom of establishing these costly facilities, but the critics are not asking them. ... [more]

BIOTECHNOLOGY RESEARCH IN AN AGE OF TERRORISM
(The National Academy of Sciences © 2003)

Biotechnology represents a “dual use” dilemma in which the same technologies can be used legitimately for human betterment and misused for bioterrorism. ... [more]

Biodefense crossing the line
(Federation of American Scientists © 2004)

The rapidity of elaboration of American biodefense programs, their ambition and administrative aggressiveness, and the degree to which they push against the prohibitions of the Biological Weapons Convention, are startling. ... [more]




Click here for more News Stories


Paid for By:
The Committee To Elect Maura Hennigan
P.O. Box 31
Boston, MA 02132
(617) 524-3100